The Bangladesh Medical Research Council (BMRC) has taken a policy decision on the COVID vaccine trial of Globe Biotech subject to conditions.
The Bangladesh Medical Research Council (BMRC) announced the decision at noon on Wednesday (June 16).
As part of the clinical trial of Globe Biotech’s vaccine, the drug administration received permission to produce the vaccine on December 28 last year. A letter was sent to BMRC on February 17 this year seeking that approval.
Earlier, on October 18 last year, the World Health Organization included three vaccines developed by Globe Biotech in the list of pre-clinical candidates.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.